Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Verona Pharma plc - American Depositary Shares (NQ:VRNA)

106.91 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	106.91
Bid (Size)	106.94 (2)
Ask (Size)	106.95 (3)
Prev. Close	106.91
Today's Range	106.91 - 106.91
52wk Range	38.45 - 106.91
Shares Outstanding	480,291,822
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

Via MarketMinute

Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗

November 13, 2025

Via Stocktwits

Performance

YTD	+121.8%	+121.8%
1 Month	N/A	N/A
3 Month	+0.9%	+0.9%
6 Month	+31.7%	+31.7%
1 Year	+169.8%	+169.8%

More News

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

Via MarketMinute

Looking Into Verona Pharma's Recent Short Interest ↗

August 20, 2025

Via Benzinga

Is the Market Bullish or Bearish on Verona Pharma? ↗

July 18, 2025

Via Benzinga

Merck Completes Acquisition of Verona Pharma

October 07, 2025

From Merck & Co., Inc.

Via Business Wire

Investing $2,000 in Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth Nearly $135,000 Today ↗

July 31, 2025

Via The Motley Fool

Does This Move Make Merck Stock a Buy? ↗

July 20, 2025

Via The Motley Fool

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, DALN, RGLD on Behalf of Shareholders

July 19, 2025

From Halper Sadeh LLC

Via GlobeNewswire

Merck Just Announced a $10 Billion Deal That Will Help Diversify Its Business ↗

July 17, 2025

Via The Motley Fool

The trading volume of these stocks is deviating from the norm in today's session. ↗

July 16, 2025

Via Chartmill

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders

July 14, 2025

From Halper Sadeh LLC

Via GlobeNewswire

This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

July 14, 2025

Via Benzinga

VERONA PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verona Pharma plc - VRNA

July 12, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Nvidia's $4 Trillion Milestone Lifts Wall Street: What's Moving Markets Wednesday? ↗

July 09, 2025

Via Benzinga

VRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verona Pharma plc Is Fair to Shareholders

July 09, 2025

From Halper Sadeh LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verona Pharma plc (Nasdaq - VRNA), Olo Inc. (NYSE - OLO), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)

July 09, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday ↗

July 09, 2025

Via Benzinga

Which stocks are gapping on Wednesday? ↗

July 09, 2025

Via Chartmill

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug ↗

July 09, 2025

Via Benzinga

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma ↗

July 09, 2025

Via Investor's Business Daily

These stocks are moving in today's pre-market session ↗

July 09, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 09, 2025

Via Benzinga

Merck To Acquire Verona For $10B In Bid To Expand Cardio-Pulmonary Pipeline ↗

July 09, 2025

Via Stocktwits

Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade

July 09, 2025

From Merck & Co., Inc.

Via Business Wire

Frequently Asked Questions

Is Verona Pharma plc - American Depositary Shares publicly traded?

Yes, Verona Pharma plc - American Depositary Shares is publicly traded.

What exchange does Verona Pharma plc - American Depositary Shares trade on?

Verona Pharma plc - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Verona Pharma plc - American Depositary Shares?

The ticker symbol for Verona Pharma plc - American Depositary Shares is VRNA on the Nasdaq Stock Market

What is the current price of Verona Pharma plc - American Depositary Shares?

The current price of Verona Pharma plc - American Depositary Shares is 106.91

When was Verona Pharma plc - American Depositary Shares last traded?

The last trade of Verona Pharma plc - American Depositary Shares was at 10/06/25 04:00 PM ET

What is the market capitalization of Verona Pharma plc - American Depositary Shares?

The market capitalization of Verona Pharma plc - American Depositary Shares is 51.35B

How many shares of Verona Pharma plc - American Depositary Shares are outstanding?

Verona Pharma plc - American Depositary Shares has 51B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.